UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000039803 |
|---|---|
| Receipt number | R000045395 |
| Scientific Title | Special Drug Use Surveillance of Alecensa Capsules in Pediatric Patients- Recurrent or refractory ALK fusion gene-positive anaplastic large cell lymphoma - |
| Date of disclosure of the study information | 2020/08/03 |
| Last modified on | 2024/01/15 14:32:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/03/13 07:37:11 | ||
| 2 | Update | 2020/03/13 09:01:34 | Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2020/07/17 09:28:36 | Date of disclosure of the study information |
|
| 4 | Update | 2020/07/17 09:29:35 | Anticipated trial start date |
|
| 5 | Update | 2020/08/03 14:33:15 | Recruitment status Date of IRB |
|
| 6 | Update | 2020/09/04 09:36:51 | Anticipated trial start date |
|
| 7 | Update | 2020/09/04 09:38:33 | Anticipated trial start date |
|
| 8 | Update | 2022/01/07 13:18:58 | Division name Division name TEL Last name of contact person Last name of contact person Division name Division name TEL Division name Division name |
|
| 9 | Update | 2022/12/28 06:52:59 | Email |
|
| 10 | Update | 2023/05/30 17:10:24 | Email |
|
| 11 | Update | 2024/01/15 14:32:12 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
